Massive 50,000-Patient study tracks new kidney drug in real life
NCT ID NCT06278207
Summary
This study is collecting information about how the drug finerenone is used in everyday medical practice for people with chronic kidney disease and type 2 diabetes. Researchers will analyze existing health records from 50,000 patients in Asia and the United States who are already taking finerenone as prescribed by their doctors. The goal is to understand who receives this medication, how they take it, and what health outcomes they experience in real-world settings.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bayer
RECRUITINGBerlin, 13353, Germany
-
Many Locations
COMPLETEDMultiple Locations, New Jersey, 07981, United States
-
Many Locations
COMPLETEDMultiple Locations, Japan
-
Many Locations
COMPLETEDMultiple Locations, Taiwan
Conditions
Explore the condition pages connected to this study.